Home/Recalls/FDA-D-0340-2026
FDA DrugsClass II

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx On...

Published: February 18, 2026Recall ID: D-0340-2026Category: drugsCountry: US

Reason for Recall / Hazard

Defective Delivery System: Missing or duplicated needles within the injection kit

Product Description & Identification

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.

Affected Products

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.

Additional Source Details

FieldValue
CityChicago
StateIL
Openfda › RouteSUBCUTANEOUS
Openfda › Rxcui283402
Openfda › Spl id1f143808-6446-45a1-9a8c-9e58a26c22cb
Openfda › Brand nameCETRORELIX ACETATE
Openfda › Spl set id9b3057ac-6cac-4509-a355-df76247b992c
Openfda › Package ndc › 171288-558-90
Openfda › Package ndc › 271288-556-02
Openfda › Package ndc › 371288-557-81
Openfda › Product ndc71288-558
Openfda › Generic nameCETRORELIX ACETATE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Manufacturer nameMeitheal Pharmaceuticals Inc.
Openfda › Application numberANDA214540
Openfda › Is original packagertrue
Event id98386
Address 18700 W Bryn Mawr Ave Ste 600s
Address 2N/A
Code infoLot Q4E0112A, Exp.: 30 Apr 2027
Postal code60631-3529
Report date20260218
Product typeDrugs
Product quantity16,477 kits
Reason for recallDefective Delivery System: Missing or duplicated needles within the injection kit
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260209
Initial firm notificationLetter
Center classification date20260223

Overview

  • Recalling FirmMeitheal Pharmaceuticals, Inc
  • StatusOngoing
  • Risk LevelClass II
  • DistributionU.S. Nationwide
Official Agency Alert